oseltamivir has been researched along with tamiphosphor in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CA; Chen, CL; Cheng, TJ; Cheng, YS; Fang, JM; Hsieh, WC; Hu, OY; Huang, PW; Jan, JT; Lin, WH; Shie, JJ; Tarbet, EB; Wang, SY; Weinheimer, S; Wong, CH | 1 |
| Albiñana, CB; Konvalinka, J; Kožíšek, M; Machara, A; Pachl, P; Řezáčová, P | 1 |
| Fang, JM; Shie, JJ; Wong, CH | 1 |
| Itoh, Y; Kanazu, T; Kitano, M; Kobayashi, M; Kodama, M; Sato, A; Yoshida, R | 1 |
| Chen, CA; Fang, JM | 1 |
| Chen, CL; Cheng, YS; Fang, JM; Jan, JT; Lin, CJ; Lin, TC; Shie, JJ; Tsai, KC; Wang, SY; Wong, CH | 1 |
| Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K | 1 |
| Berenguer Albiñana, C; Císařová, I; Hudlický, J; Konvalinka, J; Kožíšek, M; Machara, A; Navrátil, V; Pachl, P; Pokorná, J; Řezáčová, P; Rojíková, K; Šácha, P; Zemanová, J | 1 |
| Rodriguez, JD; Willett, DR | 1 |
| Basavarajappa, M; Beland, FA; Fisher, J; Gamboa da Costa, G; Loukotková, L; Lumen, A; Mattison, D; Morris, SM; Roberts, R | 1 |
| Bruner, E; Gilkeson, G; Molano, I; Nowling, TK; Rodgers, J; Sundararaj, K; Thiyagarajan, T; Wolf, B | 1 |
11 other study(ies) available for oseltamivir and tamiphosphor
| Article | Year |
|---|---|
Development of oseltamivir phosphonate congeners as anti-influenza agents.
Topics: Acetamides; Administration, Oral; Alphainfluenzavirus; Animals; Antiviral Agents; Betainfluenzavirus; Biological Availability; Blood Proteins; Cyclohexenes; Cytopathogenic Effect, Viral; Dogs; Drug Resistance, Viral; Drug Stability; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mutation; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Phosphorous Acids; Protein Binding; Rats; Structure-Activity Relationship | 2012 |
Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza.
Topics: Antiviral Agents; Catalytic Domain; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kinetics; Neuraminidase; Oseltamivir; Pandemics; Phosphorous Acids; Protein Binding; Thermodynamics | 2016 |
A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.
Topics: Acetamides; Antiviral Agents; Cyclohexenes; Humans; Influenza, Human; Oseltamivir; Phosphorous Acids | 2008 |
Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
Topics: Acids, Carbocyclic; Animals; Antiviral Agents; Body Weight; Cyclopentanes; Cyclophosphamide; Drug Administration Schedule; Female; Guanidines; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Injections, Intravenous; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Phosphorous Acids; Survival Analysis; Treatment Outcome | 2013 |
Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine.
Topics: Acetylglucosamine; Antiviral Agents; Magnetic Resonance Spectroscopy; Oseltamivir; Phosphorous Acids; Spectrometry, Mass, Electrospray Ionization | 2013 |
Tamiphosphor monoesters as effective anti-influenza agents.
Topics: Animals; Antiviral Agents; Biological Availability; Caco-2 Cells; Cell Line; Chickens; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esters; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Neuraminidase; Orthomyxoviridae; Oseltamivir; Phosphorous Acids; Structure-Activity Relationship | 2014 |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir | 2017 |
DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.
Topics: Antiviral Agents; DNA; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Phosphorous Acids; Reproducibility of Results; Viral Proteins | 2018 |
Quantitative Raman assays for on-site analysis of stockpiled drugs.
Topics: Antiviral Agents; Humans; Oseltamivir; Phosphorous Acids; Spectrum Analysis, Raman; Strategic Stockpile | 2018 |
Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys.
Topics: Animals; Antiviral Agents; Dose-Response Relationship, Drug; Female; Injections, Intravenous; Intubation, Gastrointestinal; Macaca mulatta; Molecular Conformation; Oseltamivir; Phosphorous Acids; Pregnancy | 2020 |
Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
Topics: Animals; Ceramides; Female; G(M3) Ganglioside; Glycosphingolipids; Kidney; Lactosylceramides; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Neuraminidase; Oseltamivir; Phosphorous Acids; Pilot Projects; Proteinuria | 2020 |